Ежедневный доклад об инфлюэнце в сша

Программа вакцинации Йельского университета

Программа вакцинации Йельского университета предоставляет обновленную вакцину от COVID-19 с сентября по февраль каждый год.

Вне программы вакцинации Йельского университета вакцина от COVID-19 широко доступна через ваше медицинское страхование, обычно бесплатно для вас.

Близкий контакт

Человек считается близким контактом, если он находился в пределах 6 футов от инфицированного человека в течение общей продолжительности 15 минут или более за 24-часовой период с маской или без нее.

В качестве близкого контакта вы должны наблюдать период наблюдения и тестирования. Обратите внимание, что вы не находитесь в изоляции и можете посещать занятия и ходить на работу с маской, пока у вас нет симптомов.

Дополнительная информация для соседей обучающихся студентов, проживающих в общежитии

Если вы решили остаться на месте, вы должны:

Вакцинация является основой публичного здравоохранения Йельского университета в ответ на пандемию COVID-19 и остается мощным инструментом защиты от тяжелых форм заболевания и уменьшения риска передачи вируса. Университет настоятельно рекомендует всем студентам, преподавателям, сотрудникам, аспирантам и посетителям получить все рекомендуемые Центрами по контролю и профилактике заболеваний вакцины от COVID-19, доступные для них.
Студентов, обучающихся в сфере здравоохранения, ожидается, что они будут в курсе существующей вакцины от COVID, доступной на момент зачисления, как это предусмотрено здравоохранительными требованиями на момент зачисления в университет или обратиться за разрешением на медицинские или религиозные исключения.
Бесплатная вакцинация от COVID доступна всем факультетам, сотрудникам и студентам через Программу вакцинации Йельского университета с сентября по февраль. См. раздел Как получить вакцину от COVID для руководства по получению вакцины вне этого времени.

Тестирование и симптомы

Любой, у кого появились симптомы, связанные с COVID-19, должен пройти тест с использованием быстрого антигенного теста (RA Test) как можно скорее.
Университет предоставляет бесплатные RA-тесты факультету, сотрудникам и студентам. Лица могут получить тесты, предъявив действительный идентификационный документ Йель в одном из мест, включая каждое общежитие. RA-тесты также доступны для покупки в большинстве аптек.
Если результат RA-теста отрицательный, лица должны оставаться в маске и повторить тест RA через 48 часов. Одиночный отрицательный результат RA-теста не исключает инфекции. Третий RA-тест может потребоваться через 48 часов, если симптомы сохраняются.

Статистика по развитию пандемии COVID-19 в США

По состоянию на 26 февраля 2024 года в США зарегистрировано 108 530 796 случаев заражения вирусом COVID-19. За последние сутки количество инфицированных выросло на 108 530 796 человек.

Общее количество смертей в результате коронавирусной инфекции в США достигло 1 175 495 человек, сегодня зафиксировано 1 175 495 случаев смерти. В настоящее время 1 072 841 человек находятся в активной фазе болезни, из них 1 531 в критическом состоянии. Уровень летальности составляет 1,08%. Количество подтвержденных случаев полного выздоровления от вируса на 26 февраля 2024 года в США составляет 106 282 460.

На графике ниже представлены значения подтвержденных случаев инфицирования вирусом COVID-19 в США по дням, начиная с начала сбора официальной статистики.

Нулевые значения означают отсутствие данных

Предстоящие встречи Совета безопасности (2024)

2 марта: Обсуждение мер по обеспечению безопасности на кампусе
10 марта: Планирование действий в случае ухудшения пандемиологической ситуации
18 марта: Презентация результатов исследования о масштабах заболеваемости студентов COVID-19

Понижение поддержки вакцинации детей против корь, краснухи и паротита в 2022 году

Сравнивая данные с 2019 года, больше взрослых высказались за то, чтобы родители могли решать об отсутствии вакцинации детей против корь, краснухи и паротита. Этот отказ от поддержки обязательности вакцинации от MMR для детей в публичных школах был вызван республиканцами и их сторонниками – лишь небольшинство республиканцев (56%) поддержали обязательную вакцинацию здоровых детей для посещения публичных школ, что означает снижение на 23 процентных пункта с 2019 года, когда около восьми из десяти высказывались в поддержку такого требования. Более чем четверть республиканцев и их сторонников (44%) заявили, что родители должны иметь право самостоятельно решать о вакцинации своих детей в декабре, что в два раза больше, чем в 2019 году.

Среди родителей детей младше 18 лет около двух третей (65%) поддержали обязательную вакцинацию здоровых детей для посещения публичных школ, что снижение по сравнению с 76%, кто поддерживали это в 2019 году.

Дополнительная информация для студентов-бакалавров, проживающих на кампусе

26 февраля: Встреча студентов-бакалавров по обмену опытом
4 марта: Семинар о психологическом здоровье и стрессе
10 марта: Тематический вечер Культурное многообразие на кампусе

Сбор данных, который будет прекращен после 11 мая 2023 года

После окончания чрезвычайной ситуации в области общественного здравоохранения 11 мая 2023 года истекают разрешения на сбор определенных типов данных об общественном здоровье (Таблица 1). COVID Data Tracker включает страницу для доступа к архивным данным.¶¶¶ Министерство здравоохранения больше не сможет требовать отчетности о отрицательных результатах тестирования на SARS-CoV-2 через отчеты CELR. Это изменение убирает возможность отслеживать национальный процент положительных результатов тестов на SARS-CoV-2 с использованием источника данных CELR. Данные CELR служили важным начальным индикатором передачи SARS-COV-2 во время пандемии. Тем не менее, с пиком примерно 17,4 миллиона проведенных еженедельно исследований NAAT в январе 2022 года, совпадающим с всплеском варианта SARS-CoV-2 Омикрон, количество еженедельно проведенных исследований NAAT уменьшилось до менее чем 1 миллион к 26 апреля 2023 года. Это снижение связано частично с увеличением использования антигенных тестов, а также домашним тестированием.**** Данные CELR стали более переменными в качестве или полностью недоступными во многих юрисдикциях со временем. Также будет прекращено использование уровней передачи сообщества COVID-19 Центрами по контролю заболеваний, которые, в частности, были производными от данных CELR.

Прекращение национальной отчетности об агрегированных еженедельных показателях случаев COVID-19 и связанных смертей

При окончании чрезвычайной ситуации в области общественного здравоохранения также будет прекращена отчетность по касанию суммарных еженедельных показателей случаев COVID-19 и связанных смертей, которые Центр по контролю за заболеваниями и профилактике США компилирует, используя автоматизированное извлечение данных с веб-сайтов и информационных панелей юрисдикций и прямые отчеты. Этот переход согласуется с решениями многих штатных и местных органов территориального здравоохранения о прекращении общественной отчетности по этим данным. Агрегированные показатели случаев COVID-19 были полезны для отслеживания изменяющихся тенденций в инциденте, но стали менее репрезентативными для фактических уровней инфекций SARS-CoV-2 или уровней передачи со временем, связанными с снижением лабораторного тестирования, увеличением тестирования на дому, изменениями в методах отчетности и асимптоматическими инфекциями. Ранее в пандемии агрегированная отчетность от департаментов здравоохранения предоставляла более актуальные счета всего количества смертей, чем Система виртуальных сертификатов о смерти, но своевременность Системы виртуальных сертификатов о смерти сейчас сравнима с агрегированными подсчетами (8,9). В рамках перехода от отчетности о количестве смертей к использованию данных из Системы виртуальных сертификатов о смерти будет использоваться дата смерти вместо даты отчета.

Заключение

Центры по контролю и профилактике заболеваний, на основе составного показателя, включающего уровни госпитализаций COVID-19, использование койко-дней среди пациентов с COVID-19 и показатели случаев, производные из агрегированной отчетности по числу случаев с отсутствием передачи данных о недельных случаях, CCL также прекратятся 11 мая 2023 года. Уровни госпитализации из Системы электронного мониторинга о питании и питомстве здравохранения (НССН) тесно соответствуют CCL и заменят метрику CCL. Ежемесячная отчетность о показателях случаев, госпитализаций и смертей по степени вакцинации закончится с окончанием чрезвычайной ситуации в области общественного здравоохранения.

Два трети молодых взрослых сообщают о негативном влиянии пандемии COVID-19 на их психическое здоровье

Молодые люди также сообщают о диспропорциональных эффектах от пандемии COVID-19 в марте 2022 года, особенно в отношении их психического и физического здоровья. Два трети молодых взрослых в возрасте от 18 до 29 лет (67%) сообщили, что пандемия негативно повлияла на их психическое здоровье, по сравнению с немногим больше половины лиц в возрасте от 30 до 49 лет (54%), и менее четверти лиц в возрасте от 50 до 64 лет (38%) и тех, кто старше 65 лет (37%).

KFF COVID-19 Vaccine Monitor — это постоянный исследовательский проект, отслеживающий отношение общественности к их вакцинации от COVID-19. Используя комбинацию опросов и качественного исследования, Monitor отслеживает динамическую природу общественного мнения по мере развития вакцины и ее распространения, включая уверенность и принятие вакцины, информационные потребности, надежных информаторов и сообщения, а также опыт вакцинации общественности. Список всех отчетов Vaccine Monitor доступен здесь.

Отмечается, что чернокожие взрослые на 10 процентных пунктов чаще, чем белые, верят в некоторые утверждения о вакцинации, включая то, что вакцина от COVID-19 привела к тысячам внезапных смертей у иначе здоровых людей, и что вакцина MMR доказано вызывает аутизм у детей.

Получите бесплатные быстрые антигенные тесты

Все преподаватели, сотрудники и студенты с действующим идентификационным документом Yale могут получить не более двух наборов быстрых антигенных тестов за раз.

Места выдачи быстрых антигенных тестов

Половина взрослых говорит, что они не собираются принимать меры предосторожности из-за COVID-19 этой осенью и зимой

В то время как четверть белых взрослых (39%) говорят, что они примут хотя бы одну меру предосторожности, большинство чернокожих взрослых (72%) и испаноязычных взрослых (68%) говорят, что они собираются принять любую из упомянутых мер предосторожности. По-прежнему партийная принадлежность и предыдущий уровень принятия вакцины являются сильными предикторами того, планируют ли люди принимать меры предосторожности для ограничения распространения вируса. Две трети демократов (66%) и половина независимых (48%) говорят, что они планируют принять хотя бы одну меру предосторожности, по сравнению с тремя из десяти республиканцев (29%), которые говорят то же самое. Больше половины вакцинированных взрослых (53%) говорят, что они принимают любую из мер предосторожности, по сравнению с четверью вакцинированных взрослых (39%).

Seven In Ten Women Who Were Pregnant Or Planning To Believed Or Were Unsure About At Least One Piece Of Misinformation Surrounding Pregnancy And COVID-19 Vaccines

Among those for whom questions about the safety of the vaccines and pregnancy are particularly relevant – women who are pregnant or planning to become pregnant – nearly four in ten (37%) were unsure if pregnant women should not get the vaccines and 44% were unsure if the COVID-19 vaccines cause infertility, according to the Vaccine Monitor in May, 2022. Altogether, among women who were pregnant or planning to become pregnant, 60% believed that pregnant women should not get the vaccine or were unsure if this is true, 58% believed or were unsure whether the vaccines have been shown to cause infertility, and 52% believed or were unsure whether it is unsafe for breastfeeding women to get vaccinated.

https://youtube.com/watch?v=tfjrlb9-wPg%3Fversion%3D3%26rel%3D1%26showsearch%3D0%26showinfo%3D1%26iv_load_policy%3D1%26fs%3D1%26hl%3Den-US%26autohide%3D2%26wmode%3Dtransparent

Статистика заражений коронавирусом по странам мира на сегодня, 26 февраля 2024

Быстрый доступ к статистике:

Страны мира

График официально зарегистрированных смертей с подтвержденным диагнозом коронавирус Covid-19 в США по датам.

Adults Split On Whether K-12 Schools Should Require COVID-19 Vaccines, With Significant Partisan Divides

The Influenza Hospitalization Surveillance Network (FluSurv-NET) conducts population-based surveillance for laboratory-confirmed influenza-related hospitalizations in select counties in 14 states and represents approximately 9% of the U.S. population. FluSurv-NET hospitalization data are preliminary. As data are received each week, prior case counts and rates are updated accordingly.

Among 17,799 hospitalizations, 15,564 (87.4%) were associated with influenza A virus, 2,114 (11.9%) with influenza B virus, 33 (0.2%) with influenza A virus and influenza B virus co-infection, and 88 (0.5%) with influenza virus for which the type was not determined. Among those with influenza A subtype information, 2,662 (74.4%) were A(H1N1) pdm09 and 916 (25.6%) were A(H3N2). Based on preliminary data, of the 934 laboratory-confirmed influenza-associated hospitalizations with more complete data admitted through December 2023, 5.0% (95% CI: 2.1%-7.8%) also tested positive for SARS-CoV-2.

In this figure, cumulative rates for all seasons prior to the 2023-2024 season reflect end-of-season rates. For the 2023-2024 season, rates for recent hospitals admissions are subject to reporting delays. As hospitalization data are reviewed each week, prior case counts and rates are updated accordingly.

In this figure, weekly rates for all seasons prior to the 2023-24 season reflect end-of-season rates. For the 2023-24 season, rates for recent hospital admissions are subject to reporting delays and are shown as a dashed line for the current season. As hospitalization data are received each week, prior case counts and rates are updated accordingly.

Half Said COVID-19 Pandemic Had A Negative Impact On Their Mental Health, Four In Ten On Physical Health, Financial Situation

The March, 2022 survey found the pandemic has taken a heavy toll on adults and children over the last two years. Whether it comes to their education, work, finances, mental or physical health, many – regardless of race, ethnicity and income – report feeling the negative effects of the pandemic.

The most common negative effects of the pandemic, as reported by parents, were about their children’s education and mental health. Almost two-thirds of parents said that the pandemic has negatively affected their children’s education (63%), with 28% who said it had no effect, and 9% who reported it had a positive effect. Moreover, over half (55%) of parents said the pandemic had a negative impact on their children’s mental health, compared to 36% who said it made no difference, and 9% who said it had a positive effect.

General Instructions for Everyone

In March, 2022, about six in ten adults (59%) said that now that COVID-19 case rates are lower, people should continue to wear masks in some public places to minimize the spread and avoid another surge in cases, while four in ten said that people should stop wearing masks in most public places so things can go back to normal. There were significant divides not only by partisanship, and vaccination status, but also by race, ethnicity, and income.

Eight-five percent of Democrats said that people should continue to wear masks, as did 57% of independents and 67% of vaccinated adults. Around seven in ten Republicans (69%) said that people should stop wearing masks so that things can return to normal, as did 67% of unvaccinated adults.

Calculating Isolation Times After Testing Positive

*Health care workers and students in clinical setting should isolate through day 7 and return to work/class on day 8 as long as symptoms are improving or no new symptoms develop in alignment with CDC guidelines.

Continued Surveillance After May 11, 2023

Most COVID-19 surveillance data sources will continue to be available after the public health emergency declaration ends on May 11; the reporting cadence of some will change, and three will be discontinued (Table 1). Since December 15, 2022, daily reporting to CDC’s National Healthcare Safety Network (NHSN) of aggregate counts of patients with laboratory-confirmed COVID-19 admitted to acute care and critical access U.S. hospitals has been required. After the public health emergency ends on May 11, 2023, a switch to a weekly cadence of national reporting will affect data processing and introduce reporting lag. NHSN data on COVID-19 hospital admissions per 100,000 population will be the primary surveillance indicator to help guide community and individual decisions related to risk and prevention behaviors. These data have similar suitability for tracking local COVID-19 activity as do COVID-19 Community Levels (CCLs) (8) and will be updated weekly on COVID Data Tracker at the county,¶ state, regional, and national levels.

Considerable gains in the timeliness of National Vital Statistics System (NVSS) death certificate data processing were accomplished during the pandemic (9). Provisional death certificate data from NVSS, including decedents for whom COVID-19 is listed as an underlying or a contributing cause of death, will be the primary data source for monitoring COVID-19 mortality. Among several mortality-based metrics, the percentage of COVID-19–associated deaths among all reported deaths in NVSS will be a new weekly surveillance indicator on COVID Data Tracker that is comparable with a corresponding influenza mortality surveillance indicator (Table 2).** Because the lag in mortality reporting is similar for COVID-19 deaths and deaths overall, this indicator is not biased by incomplete reporting in previous weeks and allows for timely tracking of mortality trends (8).

The National Syndromic Surveillance Program (NSSP) has expanded substantially during the COVID-19 pandemic, with data from 6,300 facilities in all 50 states, the District of Columbia, and Guam. NSSP includes 75% of all U.S. ED visits (Table 1); coverage is currently limited in Minnesota and Oklahoma, and discharge diagnosis completeness is currently limited in Missouri. Using NSSP discharge diagnosis data, the weekly percentage of patients who receive a diagnosis of COVID-19 among all ED visits is an indicator that can identify trends earlier than hospital admission rates can (8).

Monitoring national and regional trends in the percentage of positive SARS-CoV-2 nucleic acid amplification test (NAAT) results will be based on surveillance data from the National Respiratory and Enteric Virus Surveillance System (NREVSS). This system is an established sentinel network of approximately 450 clinical, public health, and commercial laboratories that voluntarily submit weekly data on numbers of positive test results and total tests performed. As another early indicator, the percentage of positive SARS-CoV-2 test results from NREVSS is a suitable alternative to that obtained through COVID-19 electronic laboratory reporting (CELR), which will not be possible after May 11, because reporting of negative rest results will not be required (8). Because SARS-CoV-2 testing volumes and the geographic representation of NREVSS laboratories are heterogeneous (with one to 31 participating laboratories per state), region-level rather than state-level data will be displayed.

Genomic surveillance to estimate SARS-CoV-2 variant proportions at the national and regional levels will continue with a biweekly cadence and revised analytic methods for weighting based on the probability of selecting positive laboratory specimens for sequencing (10). As fewer specimens and sequences become available, a system that is scaled sufficiently to allow for regional estimates will be established in collaboration with the network of public health laboratories that have participated in the National SARS-CoV-2 Strain Surveillance program.†† The National Wastewater Surveillance System (NWSS) and Traveler-based Genomic Surveillance (TGS) Program are additional sources of surveillance data for monitoring early trends in SARS-CoV-2 infections and variant proportions (NWSS) and for early detection of new variants in travelers entering the United States (TGS) that will continue to be available with daily or weekly updates.§§

To continue facilitating access to national COVID-19 surveillance data, a first-phase, redesigned COVID Data Tracker website will launch on May 11, 2023. These data will continue providing an evidence base of information to guide prioritization of public health action. Numerous surveillance data sources and corresponding metrics and geographic levels will be updated weekly on COVID Data Tracker, with visualizations of trends and maps (Table 2). County-level hospitalization data will continue to include metrics on COVID-19–associated admissions and inpatient and ICU bed occupancy. Metrics for COVID-19–associated deaths (state-level), ED visits for COVID-19 (state-level), and percentage of positive SARS-CoV-2 test results (HHS region-level) will also be displayed. Metric levels will be anchored to levels of hospital admission rates used in the CCLs (8). The COVID Data Tracker will also continue to display SARS-CoV-2 variant proportion estimates and wastewater and traveler-based genomic surveillance data, as well as vaccination data and health care data on disease severity. In addition, availability of priority data will continue after May 11, 2023, for health equity, pediatric and special populations (e.g., vaccination coverage among persons who are pregnant and those with disabilities), health care settings (e.g., nursing home residents), and seroprevalence. SARS-CoV-2 infections remain nationally notifiable, and line-level COVID-19 case surveillance data will continue to be available, including public use data at https://data.cdc.gov.

Two-Thirds Of Republicans Cite Lack Of Worry Of COVID-19 Infection As Reason For Not Getting Updated Vaccine, Half Of Democrats Say They Have Been Too Busy

Democrats’ top reasons for not getting the updated COVID-19 vaccine suggests there will likely still be additional uptake in this group, while Republicans’ top reasons may indicate more resistance to the latest vaccine. Among those who were previously vaccinated but haven’t gotten the new shot, half of Democrats (49%) say being too busy is a “major” or “minor” reason they haven’t gotten the updated vaccine yet, compared to 22% of Republicans and 35% of independents. On the other hand, two-thirds of Republicans (66%) and more than half of independents (57%) say not being worried about getting COVID is at least a minor reason why they have not gotten the updated vaccine, compared to a third of Democrats (35%).

Discussion

Beginning in 2020, the historic response to the COVID-19 pandemic necessitated rapid improvements in processing, reporting, and visualizing of timely and granular public health surveillance data on an unprecedented scale. In 2023, as part of the transition of COVID-19 from emergency to routine public health program activities, CDC has established the Coronavirus and Other Respiratory Viruses Division,†††† which is committed to working with state, tribal, local, territorial, federal, and other partners on the prevention of COVID-19 within a sustainable and integrated surveillance strategy that monitors other circulating respiratory viruses and prevention measures, including vaccination, to provide timely and comprehensive situational awareness. In the past year, CDC has developed several public dashboards displaying data on hospitalizations or ED visits for diagnosed or laboratory-confirmed COVID-19, influenza, and respiratory syncytial virus.§§§§

Acknowledgments

Lincoln Bollschweiler, Brett Burdick, Peter Colella, Cindy Friedman, Jonathan Hamer, Fiona Havers, Nesha Jairam, Iris Jiang, Jayshreema Khoosal, Saeed Muhammad, Bryan Nuckols, Kinsey Okoa, Harold Pryor, Cassandra Smith, Alexander Stubbs, Chris Taylor, Ernest Weems, Brian Wood, Fred Zagotti; Partnerships and Evaluation Branch, Office of Public Health Data, Surveillance, and Technology, CDC; Healthcare Data Advisory Unit, Data, Analytics, and Visualization Task Force, CDC COVID-19 Emergency Response Team.

1Coronavirus and Other Respiratory Viruses Division, National Center for Immunization and Respiratory Diseases, CDC; 2Office of Public Health Data, Surveillance, and Technology, CDC; 3Office of Innovation and Analytics, Agency for Toxic Substances and Disease Registry, Atlanta, Georgia; 4Division of Vital Statistics, National Center for Health Statistics, CDC; 5Division of Healthcare Quality and Promotion, National Center for Emerging and Zoonotic Diseases, CDC; 6Division of Emergency Operations, Center for Preparedness and Response, CDC; 7Booz Allen Hamilton, McLean, Virginia; 8Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Diseases, CDC; 9Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC.

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

§ https://www.cdc.gov/nchs/products/databriefs/db427.htm; https://www.cdc.gov/nchs/products/databriefs/db456.htm

¶ County-level hospital data, including new hospital admissions levels, are derived using calculations performed at the Health Service Area (HSA) level. An HSA is defined by CDC’s National Center for Health Statistics as a geographic area containing at least one county that is self-contained with respect to the population’s provision of routine hospital care. Every county in the United States is assigned to an HSA, and each HSA must contain at least one hospital. Data presented represent admissions and bed use among hospitals within the selected HSA.

†† https://www.aphl.org/aboutAPHL/publications/Documents/ID-Influenza-Right-Size-Roadmap-Edition2.pdf; https://www.aphl.org/programs/preparedness/Crisis-Management/COVID-19-Response/Pages/Sequence-Based-Surveillance-Submission.aspx

§§ State, tribal, local, and territorial health departments participating in the NWSS submit testing data to CDC. CDC standardizes, interprets, and presents these data. How often sites collect wastewater samples and how frequently data are reported to CDC varies by health department. NWSS data for SARS-CoV-2 trends are updated daily, and data for SARS-CoV-2 variants are updated weekly (https://www.cdc.gov/nwss/index.html). The Traveler-Based Genomic Surveillance Program tracks SARS-CoV-2 variants by collecting samples from international air travelers arriving from more than 30 countries at seven major U.S. airports. These samples are then sent to a laboratory network for PCR testing; all positive samples undergo genomic sequencing. https://wwwnc.cdc.gov/travel/page/travel-genomic-surveillance

*** Data on disease severity among hospitalized COVID-19 patients are obtained from three large health care data sources that contain information from subsets of U.S. hospitals: BD, PCORnet, and Premier. Although none of these sources is national in scope, viewing trends across these three data sources adds to the overall understanding of COVID-19 disease severity. https://covid.cdc.gov/covid-data-tracker/index.html#hospitalizations-severity

§§§ https://covid.cdc.gov/covid-data-tracker/#vaccine-confidence; https://www.cdc.gov/vaccines/imz-managers/coverage/covidvaxview/interactive.html

§§§§ https://www.cdc.gov/ncird/surveillance/respiratory-illnesses/index.html; https://www.cdc.gov/surveillance/resp-net/dashboard.html

What to Do if You Feel Sick or Have Symptoms

Monitor your symptoms. You may use Tylenol or ibuprofen (Advil, Motrin) for fever or body aches. If you develop worrisome new symptoms or your symptoms are getting worse, call your primary care provider. Students should call Student Health: 203-432-0312.

Call 911 Immediately if You Develop

График выявленных случаев заражения коронавирусом Covid-19 в США по датам.

References

Surveillance data source Metrics Geographic level

National Healthcare Safety Network* Count of COVID-19–associated hospital admissions County, state, regional per HHS regions, and national

Rate of COVID-19–associated hospital admissions per 100,000 population

% Change in COVID-19–associated hospital admissions from previous wk

% of inpatient beds occupied by COVID-19 patients

Absolute change in % of inpatient beds occupied by COVID-19 patients from previous wk

% of ICU beds occupied by COVID-19 patients

Absolute change in % of ICU beds occupied by COVID-19 inpatients from previous wk

National Vital Statistics System† % of all COVID-19–associated deaths State, regional per HHS regions, and national

Count of COVID-19–associated deaths

Rate of COVID-19–associated deaths per 100,000 population (crude and age-adjusted)

National Syndromic Surveillance Program§ % of ED visits with COVID-19 discharge diagnoses Select states, regional per HHS regions, and national

% Change in % of ED visits with COVID-19 from previous wk

National Respiratory and Enteric Viruses Surveillance System¶ SARS-CoV-2 NAAT % positivity Regional per HHS regions and national

% Change in SARS-CoV-2 NAAT % positivity from previous wk

National SARS-CoV-2 Strain Surveillance** Weighted and nowcast estimates of variant proportions Regional per HHS regions and national

National Wastewater Surveillance System†† Current virus levels in wastewater by site Select counties, states, regional per HHS regions, and national

% Change in the last 15 days

% of wastewater samples with detectable virus

Predominant variants by site

Relative abundance of variants by site

Traveler-based Genomic Surveillance program§§ % Test positivity (pooled) National

Variant proportions among positive pools

COVID-NET (sentinel surveillance for COVID-19–associated hospitalizations)¶¶ Rate of COVID-19–associated hospital admissions Select states and counties (sentinel network)

COVID-19–associated hospital admissions rates, by age group, sex, and race and ethnicity

% of COVID-19–associated hospitalizations by underlying medical conditions

% of COVID-19–associated hospitalizations resulting in ICU, IMV, or death

Large health care databases*** % of hospitalized COVID-19 patients who were admitted to an ICU Select participating health care organizations

% of hospitalized COVID-19 patients who received IMV

% of hospitalized COVID-19 patients who died

COVID-19 vaccinations††† % Up-to-date status 57 of 64 jurisdictions (as of April 25, 2023)

National Immunization Survey§§§ % Vaccinated and intent for vaccination National (adults and children); state (adults)

Vaccination status and intent by demographic characteristics and behavioral indicators

Abbreviations: COVID-NET = Coronavirus Disease 2019-Associated Hospitalization Surveillance Network; ED = emergency department; HHS = U.S. Department of Health and Human Services; ICU = intensive care unit; IMV = invasive mechanical ventilation; NAAT = nucleic acid amplification test. * https://www.hhs.gov/sites/default/files/covid-19-faqs-hospitals-hospital-laboratory-acute-care-facility-data-reporting.pdf. † https://www.cdc.gov/nchs/nvss/index.htm § https://www.cdc.gov/nssp/index.html ¶ https://www.cdc.gov/surveillance/nrevss/index.html ** https://covid.cdc.gov/covid-data-tracker/#variant-proportions †† https://www.cdc.gov/nwss/index.html §§ https://wwwnc.cdc.gov/travel/page/travel-genomic-surveillance. ¶¶ https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covid-net/purpose-methods.html *** https://covid.cdc.gov/covid-data-tracker/index.html#hospitalizations-severity ††† https://www.cdc.gov/vaccines/covid-19/reporting/index.html; https://www.cdc.gov/coronavirus/2019-ncov/vaccines/reporting-vaccinations.html; https://www.cdc.gov/coronavirus/2019-ncov/vaccines/stay-up-to-date.html §§§ https://www.cdc.gov/vaccines/imz-managers/nis/index.html

Suggested citation for this article: Silk BJ, Scobie HM, Duck WM, et al. COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration ― United States, May 11, 2023. MMWR Morb Mortal Wkly Rep 2023;72:523–528. DOI: http://dx.doi.org/10.15585/mmwr.mm7219e1.

MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services. Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services. References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

Majorities Of Parents Of Children Between 6 Months and 4 Years Concerned About Long-Term, Serious Side Effects Of COVID-19 Vaccine In Children

Parents’ worries about side effects and about the newness of the vaccines have been evident throughout the COVID-19 Vaccine Monitor when they explain in their own words why they would not get their young child vaccinated for COVID-19 right away. Parents’ concerns about the efficacy of the vaccine and the feeling that the vaccine is not needed have also been apparent in some of the reasons they give for not vaccinating their young child. Notably, more than four in ten (44%) Black parents of unvaccinated children under 5 years old said they were concerned they might need to take time off work to get their child vaccinated or care for them if they experience side effects. Among Hispanic parents of young unvaccinated children, 45% said they were concerned about being able to get the vaccine for their child from a place they trust and about a third (36%) expressed concern that they might have to pay an out-of-pocket cost to get their child the vaccine.

Perceived Lack Of Research, Potential Side Effects, And Safety Concerns Among The Top Reasons Why Parents Said They Won’t Vaccinate Their Young Children

Parents who had not yet vaccinated their eligible children under 5 and did not plan to do so right away when the vaccine was first being recommended to the age group offer many different reasons why they are reluctant to get their child vaccinated. Concerns about the newness of the vaccine and not enough testing or research (19%) emerged as a top reason why parents did not plan to vaccinate their young children as soon as possible. Concerns over side effects (14%) and the overall safety of the vaccines (13%) were also prominent reasons given by parents as to why they did not plan on vaccinating their young child. Some parents (11%) said they did not think their child needed the vaccine or say they were not worried about COVID-19.